Sorrento Therapeutics Inc SRNE:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:00 PM EDT
7.32UNCH (UNCH)
Volume
69,040
Close
7.32quote price arrow up+0.04 (+0.55%)
Volume
5,068,004
52 week range
2.35 - 19.39

...

Loading . . .
  • Open7.32
  • Day High7.63
  • Day Low7.26
  • Prev Close7.28
  • 52 Week High19.39
  • 52 Week High Date08/10/20
  • 52 Week Low2.35
  • 52 Week Low Date05/07/20

Key Stats

  • Market Cap2.091B
  • Shares Out285.66M
  • 10 Day Average Volume7.53M
  • Dividend-
  • Dividend Yield-
  • Beta2.39
  • YTD % Change7.25

KEY STATS

  • Open7.32
  • Day High7.63
  • Day Low7.26
  • Prev Close7.28
  • 52 Week High19.39
  • 52 Week High Date08/10/20
  • 52 Week Low2.35
  • 52 Week Low Date05/07/20
  • Market Cap2.091B
  • Shares Out285.66M
  • 10 Day Average Volume7.53M
  • Dividend-
  • Dividend Yield-
  • Beta2.39
  • YTD % Change7.25

RATIOS/PROFITABILITY

  • EPS (TTM)-1.32
  • P/E (TTM)-5.56
  • Fwd P/E (NTM)4.56
  • EBITDA (MRQ)-233.511M
  • ROE (MRQ)-244.90%
  • Revenue (MRQ)39.99M
  • Gross Margin (MRQ)75.14%
  • Net Margin (MRQ)-771.68%
  • Debt To Equity (MRQ)69.92%

EVENTS

  • Earnings Date05/13/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sorrento Therapeutics Inc

Profile

MORE
Sorrento Therapeutics, Inc. is a clinical-stage and commercial biopharma company. The Company operates through two segments: Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next generation of cancer therapeutics. These modalities include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor...
Henry Ji Ph.D.
Chairman
Najjam Asghar
Chief Financial Officer
Address
4955 Directors Pl
San Diego, CA
92121-3836
United States

Top Peers

SYMBOLLASTCHG%CHG
RVMD
Revolution Medicines Inc
30.20-1.29-4.10%
MORF
Morphic Holding Inc
48.00-3.31-6.45%
RCUS
Arcus Biosciences Inc
30.94-1.76-5.38%
BCRX
BioCryst Pharmaceuticals Inc
10.68-0.33-3.00%
MYOV
Myovant Sciences Ltd
19.51-0.50-2.50%